Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1977 2
1979 2
1980 3
1983 5
1984 5
1985 6
1986 5
1987 7
1988 12
1989 25
1990 30
1991 30
1992 42
1993 40
1994 48
1995 46
1996 55
1997 96
1998 138
1999 132
2000 164
2001 220
2002 205
2003 229
2004 290
2005 343
2006 376
2007 379
2008 434
2009 505
2010 557
2011 703
2012 855
2013 1006
2014 1044
2015 1085
2016 1234
2017 1366
2018 1359
2019 1582
2020 1829
2021 1997
2022 1976
2023 1806
2024 817

Text availability

Article attribute

Article type

Publication date

Search Results

19,533 results

Results by year

Filters applied: . Clear all
Page 1
Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies.
Paul S, Candelario-Jalil E. Paul S, et al. Exp Neurol. 2021 Jan;335:113518. doi: 10.1016/j.expneurol.2020.113518. Epub 2020 Nov 2. Exp Neurol. 2021. PMID: 33144066 Free PMC article. Review.
Stroke in most cases is caused due to an abrupt blockage of an artery (ischemic stroke), but in some instances stroke may be caused due to bleeding into brain tissue when a blood vessel ruptures (hemorrhagic stroke). Although treatment options for stroke are still l …
Stroke in most cases is caused due to an abrupt blockage of an artery (ischemic stroke), but in some instances stroke may be c …
Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
Ntaios G. Ntaios G. J Am Coll Cardiol. 2020 Jan 28;75(3):333-340. doi: 10.1016/j.jacc.2019.11.024. J Am Coll Cardiol. 2020. PMID: 31976872 Free article. Review.
The term embolic stroke of undetermined source (ESUS) was introduced in 2014 to describe patients with a nonlacunar ischemic stroke and no convincing etiology. The terms ESUS and cryptogenic stroke are not synonyms, as the latter also includes patients with multiple …
The term embolic stroke of undetermined source (ESUS) was introduced in 2014 to describe patients with a nonlacunar ischemic strok …
Colchicine in Patients with Chronic Coronary Disease.
Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T, Latchem D, Hoogslag P, Jerzewski A, Nierop P, Whelan A, Hendriks R, Swart H, Schaap J, Kuijper AFM, van Hessen MWJ, Saklani P, Tan I, Thompson AG, Morton A, Judkins C, Bax WA, Dirksen M, Alings M, Hankey GJ, Budgeon CA, Tijssen JGP, Cornel JH, Thompson PL; LoDoCo2 Trial Investigators. Nidorf SM, et al. N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31. N Engl J Med. 2020. PMID: 32865380 Clinical Trial.
METHODS: In a randomized, controlled, double-blind trial, we assigned patients with chronic coronary disease to receive 0.5 mg of colchicine once daily or matching placebo. The primary end point was a composite of cardiovascular death, spontaneous (nonprocedural) my …
METHODS: In a randomized, controlled, double-blind trial, we assigned patients with chronic coronary disease to receive 0.5 mg …
Tenecteplase Thrombolysis for Acute Ischemic Stroke.
Warach SJ, Dula AN, Milling TJ Jr. Warach SJ, et al. Stroke. 2020 Nov;51(11):3440-3451. doi: 10.1161/STROKEAHA.120.029749. Epub 2020 Oct 13. Stroke. 2020. PMID: 33045929 Free PMC article. Review.
Based on a systematic literature search, we provide a qualitative synthesis of published stroke clinical trials of tenecteplase that (1) performed randomized comparisons with alteplase, (2) compared different doses of tenecteplase, or (3) provided unique quantitativ …
Based on a systematic literature search, we provide a qualitative synthesis of published stroke clinical trials of tenecteplase that …
Acute ischemic stroke in childhood: a comprehensive review.
Mastrangelo M, Giordo L, Ricciardi G, De Michele M, Toni D, Leuzzi V. Mastrangelo M, et al. Eur J Pediatr. 2022 Jan;181(1):45-58. doi: 10.1007/s00431-021-04212-x. Epub 2021 Jul 29. Eur J Pediatr. 2022. PMID: 34327611 Free PMC article. Review.
The management of ischemic stroke in the paediatric age is often challenging because of pleomorphic age-dependent risk factors and aetiologies, high frequency of subtle or atypical clinical presentation, and lacking evidence-based data about acute recanalizat …
The management of ischemic stroke in the paediatric age is often challenging because of pleomorphic age-dependent risk factors …
Endovascular Treatment of Acute Ischemic Stroke.
Silva GS, Nogueira RG. Silva GS, et al. Continuum (Minneap Minn). 2020 Apr;26(2):310-331. doi: 10.1212/CON.0000000000000852. Continuum (Minneap Minn). 2020. PMID: 32224754 Review.
PURPOSE OF REVIEW: This article reviews the actual indications for mechanical thrombectomy in patients with acute ischemic stroke and how the opportunities for endovascular therapy can be expanded by using the concept of clinical-imaging or perfusion-imaging …
PURPOSE OF REVIEW: This article reviews the actual indications for mechanical thrombectomy in patients with acute ischemic stroke …
Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke.
Kawabori M, Shichinohe H, Kuroda S, Houkin K. Kawabori M, et al. Int J Mol Sci. 2020 Oct 6;21(19):7380. doi: 10.3390/ijms21197380. Int J Mol Sci. 2020. PMID: 33036265 Free PMC article. Review.
Various types of cells, including bone marrow mononuclear cells, bone marrow/adipose-derived stem/stromal cells, umbilical cord blood cells, neural stem cells, and olfactory ensheathing cells have enhanced neurological outcomes in animal stroke models. These stem cells have also …
Various types of cells, including bone marrow mononuclear cells, bone marrow/adipose-derived stem/stromal cells, umbilical cord blood cells, …
Emerging agents for the treatment and prevention of stroke: progress in clinical trials.
Safouris A, Magoufis G, Tsivgoulis G. Safouris A, et al. Expert Opin Investig Drugs. 2021 Oct;30(10):1025-1035. doi: 10.1080/13543784.2021.1985463. Epub 2021 Oct 13. Expert Opin Investig Drugs. 2021. PMID: 34555978 Review.
AREAS COVERED: The current review highlights pharmaceutical agents under evaluation in clinical trials concerning the acute, subacute, and chronic phase post-stroke. ...This tendency enriches the therapeutic armamentarium with novel agents developed for specific stroke sub …
AREAS COVERED: The current review highlights pharmaceutical agents under evaluation in clinical trials concerning the acute, subacute …
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack.
Brown DL, Levine DA, Albright K, Kapral MK, Leung LY, Reeves MJ, Sico J, Strong B, Whiteley WN; American Heart Association Stroke Council. Brown DL, et al. Stroke. 2021 Jul;52(7):e468-e479. doi: 10.1161/STR.0000000000000377. Epub 2021 May 24. Stroke. 2021. PMID: 34024115 Free article.
BACKGROUND: Dual antiplatelet therapy (DAPT) after ischemic stroke or transient ischemic attack may reduce recurrent stroke but also increase severe bleeding compared with single antiplatelet therapy (SAPT). ...In these trials, DAPT, compared with SAPT, was associat …
BACKGROUND: Dual antiplatelet therapy (DAPT) after ischemic stroke or transient ischemic attack may reduce recurrent stroke bu …
Endovascular treatment for acute basilar artery occlusion: A multicenter randomized controlled trial (ATTENTION).
Tao C, Li R, Zhu Y, Qun S, Xu P, Wang L, Zhang C, Liu T, Song J, Sun W, Wang G, Baxter B, Qureshi A, Liu X, Nogueira RG, Hu W. Tao C, et al. Int J Stroke. 2022 Aug;17(7):815-819. doi: 10.1177/17474930221077164. Epub 2022 Feb 22. Int J Stroke. 2022. PMID: 35102797 Clinical Trial.
STUDY DESIGN: ATTENTION is an investigator-initiated, multicenter, prospective, randomized, controlled clinical trial with open-label treatment and blinded outcome assessment (PROBE) of EVT versus best medical management (BMM). ...DISCUSSION: ATTENTION will p …
STUDY DESIGN: ATTENTION is an investigator-initiated, multicenter, prospective, randomized, controlled clinical trial w …
19,533 results
You have reached the last available page of results. Please see the User Guide for more information.